
    
      Patients who had acute STEMI and successfully reperfused by either thrombolytic therapy or
      primary angioplasty and stenting will be included this study.

      A basal routine echocardiography will be obtained in all patients after reperfusion therapy.
      Thereafter, patients will be divided into two groups: 1.Treatment group will receive
      transthoracic echocardiography using Philips HD11 XE ® for 30 minutes qid for 4 days. 2.
      Placebo group will have the same Philips HD11 XE ® echo transducer applied for the same time
      and duration on their chest but with the ultrasound turned-off. Detailed left and right
      ventricle function as well as performance index and stress-strain imaging will be obtained
      and analyzed at 3 and 6 months.
    
  